Search Results - "Starczynowski, Daniel"

Refine Results
  1. 1

    Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS by Trowbridge, Jennifer J, Starczynowski, Daniel T

    Published in The Journal of experimental medicine (05-07-2021)
    “…With a growing aged population, there is an imminent need to develop new therapeutic strategies to ameliorate disorders of hematopoietic aging, including…”
    Get full text
    Journal Article
  2. 2

    IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies by Bennett, Joshua, Starczynowski, Daniel T.

    Published in Current opinion in hematology (01-01-2022)
    “…Cell intrinsic and extrinsic perturbations to inflammatory signaling pathways are a hallmark of development and progression of hematologic malignancies. The…”
    Get full text
    Journal Article
  3. 3

    Chronic immune response dysregulation in MDS pathogenesis by Barreyro, Laura, Chlon, Timothy M., Starczynowski, Daniel T.

    Published in Blood (11-10-2018)
    “…Chronic innate immune signaling in hematopoietic cells is widely described in myelodysplastic syndromes (MDS), and innate immune pathway activation,…”
    Get full text
    Journal Article
  4. 4

    Nuclear deubiquitination in the spotlight: the multifaceted nature of USP7 biology in disease by Rawat, Radhika, Starczynowski, Daniel T, Ntziachristos, Panagiotis

    Published in Current opinion in cell biology (01-06-2019)
    “…Ubiquitination is a versatile and tightly regulated post-translational protein modification with many distinct outcomes affecting protein stability,…”
    Get full text
    Journal Article
  5. 5
  6. 6

    TIFA and TIFAB: FHA-domain proteins involved in inflammation, hematopoiesis, and disease by Niederkorn, Madeline, Agarwal, Puneet, Starczynowski, Daniel T.

    Published in Experimental hematology (01-10-2020)
    “…•FHA domain-containing proteins are critical gatekeepers of diverse signaling pathways.•TIFA and TIFAB are critical FHA domain-containing proteins in…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs by Muto, Tomoya, Walker, Callum S., Choi, Kwangmin, Hueneman, Kathleen, Smith, Molly A., Gul, Zartash, Garcia-Manero, Guillermo, Ma, Averil, Zheng, Yi, Starczynowski, Daniel T.

    Published in Nature immunology (01-05-2020)
    “…Despite evidence of chronic inflammation in myelodysplastic syndrome (MDS) and cell-intrinsic dysregulation of Toll-like receptor (TLR) signaling in MDS…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia by Chlon, Timothy M., Stepanchick, Emily, Hershberger, Courtney E., Daniels, Noah J., Hueneman, Kathleen M., Kuenzi Davis, Ashley, Choi, Kwangmin, Zheng, Yi, Gurnari, Carmelo, Haferlach, Torsten, Padgett, Richard A., Maciejewski, Jaroslaw P., Starczynowski, Daniel T.

    Published in Cell stem cell (04-11-2021)
    “…DDX41 mutations are the most common germline alterations in adult myelodysplastic syndromes (MDSs). The majority of affected individuals harbor germline…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Sequential CRISPR gene editing in human iPSCs charts the clonal evolution of myeloid leukemia and identifies early disease targets by Wang, Tiansu, Pine, Allison R., Kotini, Andriana G., Yuan, Han, Zamparo, Lee, Starczynowski, Daniel T., Leslie, Christina, Papapetrou, Eirini P.

    Published in Cell stem cell (03-06-2021)
    “…Human cancers arise through the sequential acquisition of somatic mutations that create successive clonal populations. Human cancer evolution models could help…”
    Get full text
    Journal Article
  13. 13

    Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype by Kuchenbauer, Florian, Lam, Wan, Hogge, Donna, Humphries, R Keith, Marra, Marco, Morin, Ryan, Wells, Richard A, Buckstein, Rena, Hirst, Martin, Starczynowski, Daniel T, Sung, Sandy, Muranyi, Andrew, Karsan, Aly, Argiropoulos, Bob

    Published in Nature medicine (01-01-2010)
    “…For myelodysplastic syndromes caused by deletion of chromosome 5q, Daniel Starczynowski et al . provide evidence that decreased expression of two miRNAs in…”
    Get full text
    Journal Article
  14. 14

    DDX41 haploinsufficiency causes inefficient hematopoiesis under stress and cooperates with p53 mutations to cause hematologic malignancy by Stepanchick, Emily, Wilson, Andrew, Sulentic, Analise M., Choi, Kwangmin, Hueneman, Kathleen, Starczynowski, Daniel T., Chlon, Timothy M.

    Published in Leukemia (01-08-2024)
    “…Germline heterozygous mutations in DDX41 predispose individuals to hematologic malignancies in adulthood. Most of these DDX41 mutations result in a truncated…”
    Get full text
    Journal Article
  15. 15

    Chemotherapy resistance in acute myeloid leukemia is mediated by A20 suppression of spontaneous necroptosis by Culver-Cochran, Ashley E., Hassan, Aishlin, Hueneman, Kathleen, Choi, Kwangmin, Ma, Averil, VanCauwenbergh, Brett, O’Brien, Eric, Wunderlich, Mark, Perentesis, John P., Starczynowski, Daniel T.

    Published in Nature communications (24-10-2024)
    “…Acute myeloid leukemia (AML) is a deadly hematopoietic malignancy. Although many patients achieve complete remission with standard induction therapy, a…”
    Get full text
    Journal Article
  16. 16

    A calcium- and calpain-dependent pathway determines the response to lenalidomide in myelodysplastic syndromes by Fang, Jing, Liu, Xiaona, Bolanos, Lyndsey, Barker, Brenden, Rigolino, Carmela, Cortelezzi, Agostino, Oliva, Esther N, Cuzzola, Maria, Grimes, H Leighton, Fontanillo, Celia, Komurov, Kakajan, MacBeth, Kyle, Starczynowski, Daniel T

    Published in Nature medicine (01-07-2016)
    “…Lenalidomide, which is used to treat myelodysplastic syndrome, kills mutation-bearing hematopoietic cells by increasing expression of the G-protein-coupled…”
    Get full text
    Journal Article
  17. 17

    GMP-ing to Spatial Conclusions about Emergency and Leukemic Myelopoiesis by Niederkorn, Madeline, Starczynowski, Daniel T.

    Published in Cell stem cell (04-05-2017)
    “…Hematopoietic stem cells (HSCs) in the bone marrow (BM) form mature blood cells of all lineages through expansion of lineage-biased progenitors. In a recent…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation by Muto, Tomoya, Walker, Callum S, Agarwal, Puneet, Vick, Eric, Sampson, Avery, Choi, Kwangmin, Niederkorn, Madeline, Ishikawa, Chiharu, Hueneman, Kathleen, Varney, Melinda, Starczynowski, Daniel T

    Published in Haematologica (Roma) (01-10-2023)
    “…Inflammation is associated with the pathogenesis of myelodysplastic syndromes (MDS) and emerging evidence suggests that MDS hematopoietic stem and progenitor…”
    Get full text
    Journal Article